Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.
We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.
We have developed a systemic approach that brings together the human networks, processes and scientific tools necessary for collecting, analysing and reporting on the many aspects of the European drugs phenomenon.
Zepbound And Weight Loss Drugs Offer ‘paradigm Shift,’ Doctor Says Wagovie
Location
Lisbon
Publication date
Reference
News release
In United States Publish Post Time: 2025-08-22
Dr. Natalie Azar weighs in on the medication called Zepbound that was just approved by the FDA and how the new weight loss drugs on the market are offering a “paradigm shift” for how obesity is treated and conceptualized. “It is not just a behavior failure,” she says.
» Subscribe to TODAY:
» Watch the latest from TODAY:
About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series.
Connect with TODAY Online!
Visit TODAY's Website:
Find TODAY on Facebook:
Follow TODAY on Twitter:
Follow TODAY on Instagram:
Zepbound And Weight Loss Drugs Offer ‘paradigm Shift,’ Doctor Says For Country: United States. City: McAllen, Portland, Salinas, St. Petersburg, Waterbury
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:
Kathy Robertson
Principal manager
Media relations and corporate communication